These results may lead to a conclusion that imbalance in substance P/neurokinin 1 and the μ-opioid neuropeptide system may be responsible for increased opioid sensitivity as well as for respiratory depressant function in OSA patients. The gene discussed is TAC1; the disease is obstructive sleep apnea syndrome.